Received Sep 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | LA |
Had Covid 3 times; Had Covid 3 times; This is a spontaneous report received from a Consumer or other non HCP. A 67-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing), notes: Rheumatoid arthritis; "Overactive bladder" (unspecified if ongoing), notes: Overactive bladder; "Slightly elevated blood pressure" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN taken for blood pressure increased. The patient also took other concomitant therapy. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 2022, outcome "unknown" and all described as "Had Covid 3 times". Therapeutic measures were taken as a result of covid-19, drug ineffective. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500186983 Same patient, drug and event, different dose, separated in time;US-PFIZER INC-202500186984 Same patient, drug and event, different dose, separated in time;
Medical History/Concurrent Conditions: Blood pressure increased; Overactive bladder; Rheumatoid arthritis
LOSARTAN